This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Wall Street Analysts Think Vital Farms (VITL) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Vital Farms (VITL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
How Will the Sale of 51.8% Interest in Agro Tech Foods Aid CAG Stock?
by Zacks Equity Research
Conagra announces the completion of the divestiture of its 51.8% ownership stake in Agro Tech Foods that is set to enhance its portfolio.
The J.M. Smucker Q1 Earnings Top Estimates, SJM Stock Down on View Cut
by Zacks Equity Research
J.M.Smucker's Q1 show reflects sales and earnings growth despite a tough consumer landscape. SJM cuts view due to a dynamic landscape and green coffee costs.
Has The New York Times Company (NYT) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how New York Times Co. (NYT) and Vital Farms (VITL) have performed compared to their sector so far this year.
CENT Stock Declines 11% in 3 Months: Should You Buy, Hold or Sell?
by Zacks Equity Research
Central Garden & Pet Company is facing softness in new pet adoptions as well as lower foot traffic at home center retailers.
Hain Celestial Q4 Earnings Top, Hain Reimagined Strategy Yields
by Zacks Equity Research
HAIN's fourth-quarter fiscal 2024 results show increased earnings on the back of the effectiveness of the Hain Reimagined strategy despite a year-over-year decline in sales.
Vital Farms (VITL) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Vital Farms (VITL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Medifast's (MED) Strategies Aid Amid Evolving Market Demands
by Zacks Equity Research
Medifast (MED) is making efforts to thrive in the rapidly evolving weight loss market, as the adoption of GLP-1 medications reshapes industry dynamics.
BJ's Wholesale (BJ) Stock Falls Despite Q2 Earnings Beat, Comps Growth
by Zacks Equity Research
BJ's Wholesale Club's (BJ) second-quarter earnings results reflect growth in digitally enabled comparable sales. The metric surges 22% during the quarter.
Zacks.com featured highlights Vital Farms, PulteGroup, Hamilton Insurance, Greenbrier and Kratos
by Zacks Equity Research
Vital Farms, PulteGroup, Hamilton Insurance, Greenbrier and Kratos have been highlighted in this Screen of The Week article.
Ollie's (OLLI) Expands Supply With New Distribution Hub
by Zacks Equity Research
Ollie's (OLLI) expansion of its distribution center in Princeton underscores the company's commitment to delivering exceptional value to customers.
5 Low-Leverage Stocks to Buy on an Optimistic Fed Minutes Report
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt. You can buy low-leverage stocks like VITL, PHM, HG, GBX and KTOS.
Colgate (CL) Benefits From Innovation & Pricing Actions
by Zacks Equity Research
Colgate's (CL) margins benefit from robust pricing and funding-the-growth and other productivity initiatives.
COTY's Q4 Loss Wider Than Estimates, Sales Increase Y/Y
by Zacks Equity Research
COTY's fourth-quarter fiscal 2024 results reflect growth in the Consumer Beauty segments. However, the bottom line declines year over year.
Target (TGT) Q2 Earnings Beat Estimates, Comps Rise Y/Y
by Zacks Equity Research
Target (TGT) achieves comparable sales growth in the second quarter, rebounding from past challenges. The retail bellwether witnesses increased traffic both in stores and across digital channels.
Conagra Brands (CAG) Troubled by Slowdown in Consumption Trends
by Zacks Equity Research
Conagra Brands (CAG) has been witnessing challenging industry trends, including a slowdown in consumption. The company expects volumes to be soft in the first quarter of fiscal 2025.
Archer Daniels (ADM) & FBN Launch Gradable to Boost Technology
by Zacks Equity Research
Archer Daniels (ADM) and Farmers Business Network launch a joint venture, Gradable, to boost technology solutions.
United Natural (UNFI) Stock Down More Than 15% YTD: Here's Why
by Zacks Equity Research
United Natural (UNFI) is battling challenges like reduced consumer spending, weakness in the Retail business and margin pressure.
Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?
by Zacks Equity Research
Nu Skin (NUS) has been battling persistent macroeconomic headwinds, which have been weighing on consumer spending and customer acquisition. Strong currency headwinds are also playing foul.
3 Stocks to Buy on Solid Jump in Online Grocery Sales
by Ritujay Ghosh
Stocks like Vital Farms, Inc. (VITL), Pilgrim's Pride Corporation (PPC) and Ingredion Incorporated (INGR) are poised to benefit from the jump in in online grocery sales.
Flowers Foods (FLO) Q2 Earnings Beat Estimates, Sales Down Y/Y
by Zacks Equity Research
Flowers Foods' (FLO) second-quarter fiscal 2024 results reflect higher earnings on strong operational performance. However, sales decline year over year due to lower volumes.
Estee Lauder (EL) Q4 Earnings Top, Asia Travel Retail Sluggish
by Zacks Equity Research
Estee Lauder's (EL) Q4 results reflect increased earnings and sales despite sluggishness in core business areas, especially mainland China, Asia travel retail and North America.
Energizer (ENR) Gains From Project Momentum & Debt Reduction
by Zacks Equity Research
Energizer (ENR) is well-positioned for long-term success and shareholder value, with a focus on consumer engagement, market expansion, innovation and effective debt reduction.
Helen of Troy's (HELE) Stock Down More Than 57% YTD: Here's Why
by Zacks Equity Research
Helen of Troy (HELE) is facing a tough operational environment, heightened macroeconomic uncertainty and a financially-strained consumer environment.
Kellanova (K) Stock Jumps 10% in a Week: What's the Buzz About?
by Zacks Equity Research
Kellanova's (K) stock surge follows Mars' plan to acquire the company. The deal aligns well for both companies, with Kellanova set to gain from Mars' global reach and resources.